Aller au contenu principal
2025 article

The use of the odds ratio product and self-reported data to detect comorbid insomnia and sleep apnea

3Citations signalées — pas une note de qualité
9Institutions déclarées
6Pays d’affiliation déclarés

Résumé fourni par la source

STUDY OBJECTIVES: To evaluate the utility of the odds ratio product (ORP) in differentiating comorbid insomnia and sleep apnea (COMISA) from obstructive sleep apnea (OSA) and chronic insomnia (CIN). METHODS: We retrospectively analyzed 9750 patients in four groups: (1) 1152 controls, (2) 2395 with CIN, (3) 2297 with OSA, and (4) 3906 with COMISA. CIN was defined as difficulty initiating/maintaining sleep with daytime fatigue/sleepiness occurring "often"/"always." OSA was defined as an apnea-hypopnea index ≥5 on polysomnography. ORP, computed every 3 s from polysomnography, was analyzed alongside sleep metrics, comorbidities, and sleep habits. Associations were assessed using univariate multinomial logistic regression, followed by stepwise regression to identify independent predictors of COMISA versus OSA or CIN. Machine learning models classified COMISA, OSA, and CIN as distinct clinical groups. RESULTS: ORP-derived features showed stronger associations with COMISA than traditional sleep metrics (except N3 latency). Independent objective predictors of COMISA included male sex (OR = 1.31, 95% CI = [1.16, 1.47]), BMI (1.27, [1.25, 1.29]), N3 latency (1.21, [1.13, 1.29]), age (1.17, [1.16, 1.19]), peak ORP during spontaneous arousals (1.12, [1.01, 1.25]), and time in ORP decile 7 (1.10, [1.07, 1.13]). Subjective predictors included depression, hypertension, allergy, headache, sleep aid/alcohol use, sleepiness, and lower sleep duration. Machine learning achieved overall accuracy of 61.2 per cent (p<.05), with sensitivity of 71 per cent for COMISA, 65 per cent for OSA, and 43 per cent for CIN. CONCLUSIONS: ORP is a promising objective marker for COMISA, distinguishing it from OSA more effectively than sleep metrics but separating COMISA from CIN poorly. Statement of Significance This study highlights the potential of the odds ratio product (ORP) as a novel objective marker to complement self-report questionnaires for identifying comorbid insomnia and sleep apnea (COMISA). Our findings demonstrate that ORP, combined with demographics and self-reported comorbidities and sleep habits, can distinguish COMISA from obstructive sleep apnea more effectively than traditional polysomnography metrics. These findings may refine the current understanding of COMISA from a research perspective and, in the future, may have clinical implications for improving the diagnosis and management of the disorder, which is often underrecognized in clinical patients who are evaluated for sleep-disordered breathing. Future studies should explore how ORP can be integrated into clinical sleep assessments and diagnostic strategies.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
The use of the odds ratio product and self-reported data to detect comorbid insomnia and sleep apnea
Date Crossref
15/07/2025
Éditeur
Oxford University Press (OUP)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Sleep and related disordersObstructive Sleep Apnea ResearchRestless Legs Syndrome Research

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.